Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Microneedles: Report describes progress in new technology for painless drug delivery

18.11.2003


New fabrication results



The paper describes research at the Georgia Institute of Technology on fabricating hollow and solid microneedles in a variety of sizes and shapes from metals, biodegradable polymers, silicon and glass. It also reports on testing with cadaver skin and animals that demonstrates the ability of the micron-scale needles to deliver proteins, nanoparticles, and both small and large molecules through the skin.

"We’ve opened up the potential use of microneedles for delivering a broad range of therapeutics," said Mark Prausnitz, a professor in Georgia Tech’s School of Chemical and Biomolecular Engineering and principal investigator for the project. "Fabricating both hollow and solid microneedles in a variety of shapes, sizes and materials allows us to deliver large molecules with significant therapeutic interest such as insulin, proteins produced by the biotechnology industry, and nanoparticles that could encapsulate a drug or demonstrate the ability to deliver a virus for vaccinations."


Georgia Tech’s development of microneedles began in the late 1990s with microfabrication of solid needles made from silicon, using microlithography and etching technologies originally developed for the microelectronics industry. The researchers produced arrays of up to 400 needles designed to punch holes in the outer layer of skin to increase its permeability to small molecules applied with patches.

That work has broadened to include both solid and hollow microneedles in a broad range of shapes with feature sizes from one to 1,000 microns. Prausnitz and his research team have fabricated microneedle arrays from metal and polymer materials that have sufficient strength to reliably penetrate the skin without breakage.

Moving beyond the original – and complex – microelectronics-based fabrication techniques, the researchers have developed multiple manufacturing processes suitable for the mass production of microneedles from inexpensive metal and polymer materials. By making molds of their silicon needles, for instance, the research team has produced arrays of identical metal or polymer microneedles using a modified form of injection molding that can readily be adapted to industrial mass production.

Molds were also made without the need for creating silicon needles to use as masters. Metal microneedles were produced through electrodeposition onto laser-drilled polymer molds, while glass microneedle masters were fabricated using conventional drawn-glass micropipette techniques.

The broad range of sizes, shapes and materials will permit production of microneedle arrays customized for the type and volume of drug to be delivered, the time period of use, and most importantly, minimizing pain.

"There are trade offs between getting needles to go into the skin easily, getting drugs to deliver easily and making needles that don’t hurt," Prausnitz said. "Not every application will need a different needle, but there will probably be classes of applications that will benefit from different needle designs."

Among the potential applications are:
  • Arrays of hollow needles could be used to continuously carry drugs into the body using simple diffusion or a pump system;

  • Hollow microneedles could be used to remove fluid from the body for analysis – such as blood glucose measurements – and to then supply microliter volumes of insulin or other drug as required;

  • Microneedles may prove useful for immunization programs in developing countries or for the mass vaccination or administration of antidotes in bioterrorism incidents because they could be applied by persons with minimal medical training, and

  • Very small microneedles could provide highly targeted drug administration to individual cells.

Microneedles are expected to be less painful than conventional hypodermic needles because they are too small to significantly stimulate nerve endings, Prausnitz said. Small-scale studies so far have confirmed that expectation, and additional pain studies are planned. The safety and effectiveness of microneedles must still be proven in humans before they can receive Food & Drug Administration approval for clinical use.

Before microneedles find widespread use, the researchers must perfect the techniques for optimally inserting them into the skin, and complete the integration of microneedles into a full drug delivery system. The need to minimize variability in needle insertion is being addressed in part by development of an applicator device that would be part of the delivery system.

Several companies are pursuing development of microneedles, including some that are conducting clinical trials.

"There is an aggressive movement toward bringing microneedles to the market," Prausnitz said. "We’ve shown that microneedles can serve as a hybrid drug delivery system, combining the advantages of conventional needles – which deliver drugs easily – with transdermal patches that are more patient-friendly. I expect that within the next five years, a microneedle device will become available for clinical use."


Beyond Prausnitz, the research team includes Devin McAllister, Ping Wang, Shawn Davis, Jung-Hwan Park, Paul Canatella and Mark Allen. The research has been sponsored by the National Institutes of Health (NIH), the National Science Foundation (NSF), the American Diabetes Association and the Defense Advanced Research Projects Agency (DARPA).

John Toon | EurekAlert!
Further information:
http://gtresearchnews.gatech.edu/

More articles from Process Engineering:

nachricht A water treatment breakthrough, inspired by a sea creature
27.11.2018 | Yale University

nachricht Research project AutoAdd: Paving the way for additive manufacturing for the automotive industry
22.11.2018 | Fraunhofer-Institut für Lasertechnik ILT

All articles from Process Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>